# Effects of Raltegravir (Isentress®) on Lipid and Carbohydrate Metabolism and Mitochondrial Function in Healthy Volunteers

> **NCT00772720** · PHASE1 · UNKNOWN · sponsor: **Hospital Clinic of Barcelona** · enrollment: 14 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** raltegravir
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00772720
- **Lead sponsor:** Hospital Clinic of Barcelona
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-03
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 14 (ESTIMATED)
- **Last updated:** 2010-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00772720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00772720, "Effects of Raltegravir (Isentress®) on Lipid and Carbohydrate Metabolism and Mitochondrial Function in Healthy Volunteers". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00772720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*